Journey Medical Statistics
Total Valuation
Journey Medical has a market cap or net worth of $187.97 million. The enterprise value is $187.87 million.
| Market Cap | 187.97M |
| Enterprise Value | 187.87M |
Important Dates
The last earnings date was Wednesday, August 12, 2026, after market close.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Journey Medical has 28.22 million shares outstanding. The number of shares has increased by 21.63% in one year.
| Current Share Class | 22.22M |
| Shares Outstanding | 28.22M |
| Shares Change (YoY) | +21.63% |
| Shares Change (QoQ) | +0.69% |
| Owned by Insiders (%) | 11.59% |
| Owned by Institutions (%) | 37.65% |
| Float | 15.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 32.71 |
| PS Ratio | 2.72 |
| Forward PS | 1.84 |
| PB Ratio | 5.56 |
| P/TBV Ratio | 28.04 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.71 |
| EV / EBITDA | 152.18 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.80.
| Current Ratio | 1.59 |
| Quick Ratio | 1.35 |
| Debt / Equity | 0.80 |
| Debt / EBITDA | 19.32 |
| Debt / FCF | n/a |
| Interest Coverage | -0.82 |
Financial Efficiency
Return on equity (ROE) is -23.77% and return on invested capital (ROIC) is -9.85%.
| Return on Equity (ROE) | -23.77% |
| Return on Assets (ROA) | -2.09% |
| Return on Invested Capital (ROIC) | -9.85% |
| Return on Capital Employed (ROCE) | -5.72% |
| Weighted Average Cost of Capital (WACC) | 10.35% |
| Revenue Per Employee | $1.18M |
| Profits Per Employee | -$105,241 |
| Employee Count | 58 |
| Asset Turnover | 0.76 |
| Inventory Turnover | 2.24 |
Taxes
In the past 12 months, Journey Medical has paid $15,000 in taxes.
| Income Tax | 15,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.05% in the last 52 weeks. The beta is 1.08, so Journey Medical's price volatility has been similar to the market average.
| Beta (5Y) | 1.08 |
| 52-Week Price Change | -7.05% |
| 50-Day Moving Average | 6.59 |
| 200-Day Moving Average | 7.01 |
| Relative Strength Index (RSI) | 47.76 |
| Average Volume (20 Days) | 220,312 |
Short Selling Information
The latest short interest is 2.87 million, so 10.19% of the outstanding shares have been sold short.
| Short Interest | 2.87M |
| Short Previous Month | 3.05M |
| Short % of Shares Out | 10.19% |
| Short % of Float | 19.13% |
| Short Ratio (days to cover) | 17.88 |
Income Statement
In the last 12 months, Journey Medical had revenue of $68.18 million and -$6.10 million in losses. Loss per share was -$0.23.
| Revenue | 68.18M |
| Gross Profit | 44.63M |
| Operating Income | -3.01M |
| Pretax Income | -6.09M |
| Net Income | -6.10M |
| EBITDA | 1.22M |
| EBIT | -3.01M |
| Loss Per Share | -$0.23 |
Balance Sheet
The company has $25.64 million in cash and $25.54 million in debt, with a net cash position of $102,000 or $0.00 per share.
| Cash & Cash Equivalents | 25.64M |
| Total Debt | 25.54M |
| Net Cash | 102,000 |
| Net Cash Per Share | $0.00 |
| Equity (Book Value) | 32.11M |
| Book Value Per Share | 1.16 |
| Working Capital | 27.01M |
Cash Flow
| Operating Cash Flow | -7.49M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 4.22M |
| Net Borrowing | n/a |
| Free Cash Flow | -7.49M |
| FCF Per Share | -$0.27 |
Margins
Gross margin is 65.45%, with operating and profit margins of -4.41% and -8.95%.
| Gross Margin | 65.45% |
| Operating Margin | -4.41% |
| Pretax Margin | -8.93% |
| Profit Margin | -8.95% |
| EBITDA Margin | 1.78% |
| EBIT Margin | -4.41% |
| FCF Margin | n/a |
Dividends & Yields
Journey Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.63% |
| Shareholder Yield | -21.63% |
| Earnings Yield | -3.30% |
| FCF Yield | -4.05% |
Analyst Forecast
The average price target for Journey Medical is $13.75, which is 106.46% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.75 |
| Price Target Difference | 106.46% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 47.12% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Journey Medical has an Altman Z-Score of 1.19 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.19 |
| Piotroski F-Score | 2 |